SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-15-046420
Filing Date
2015-02-12
Accepted
2015-02-12 14:45:06
Documents
2
Group Members
PUBLIC JOINT STOCK CO PHARMSTANDARD

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G d869934dsc13g.htm SC 13G 55758
2 EX-99.1 d869934dex991.htm EX-99.1 4906
  Complete submission text file 0001193125-15-046420.txt   62221
Mailing Address 4233 TECHNOLOGY DR DURHAM NC 27704
Business Address 4233 TECHNOLOGY DR DURHAM NC 27704 9192876300
ARGOS THERAPEUTICS INC (Subject) CIK: 0001105533 (see all company filings)

IRS No.: 562110007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88006 | Film No.: 15605250
SIC: 2834 Pharmaceutical Preparations

Mailing Address 65 BOULEVARD GRANDE DUCHESSE CHARLOTTE LUXEMBOURG N4 L-1528
Business Address 65 BOULEVARD GRANDE DUCHESSE CHARLOTTE LUXEMBOURG N4 L-1528 352 26449 557
Pharmstandard International S.A. (Filed by) CIK: 0001598762 (see all company filings)

IRS No.: 000000000
Type: SC 13G